Guidelines

The EAACI Guidelines provide evidence-based recommendations for your clinical practice on a variety of topics. These are formulated by multi-disciplinary working groups with a strong methodological base, aiming to provide indications and contraindications, identifying gaps in knowledge and/or implementation, unmet needs and future perspectives. EAACI Guidelines are a necessary resource with the goal of homogenizing clinical practice and provide the best treatment strategies for patients internationally. Read and implement them here!

All Guidelines

Filter

What are you looking for?

Category
- Aerobiology and pollution
- Allergen immunotherapy
- Allergy diagnosis
- Allied health and primary care
- Asthma
- Basic immunology
- Dermatology
- Drug allergy
- ENT
- Environmental allergy and climate change
- Food allergy
- Food Allergy and Anaphylaxis
- Occupational allergy
- Ocular allergy
- OMIC Technologies in Allergy Research
- Pediatrics
- Systems medicine
- T2 Diseases
Year
- 2013
- 2014
- 2015
- 2016
- 2017
- 2019
- 2020
- 2021
- 2022
Keywords
- “omics” and systems biology
- (reverse) zoonosis
- AAMP
- ACE2
- acute respiratory tract infection
- adolescent
- Adolescents
- adults
- adverse drug reaction
- aerd
- aerobiology
- AIT
- Algorithm
- allergen
- allergen immunotherapy
- allergen immunotherapy (AIT)
- allergen-immuntherapie
- allergens and epitopes
- allergic asthma
- allergic disease
- allergic diseases
- allergic rhinitis
- allergicdiseases
- allergicrhinitis
- allergie
- allergy
- allergy diagnosis
- allergy epidemiology
- allergy hypersensititvy
- allergy management
- Allergy risk
- allergy test
- allergy treament
- allergy treatment
- allergy/hypersensitivity
- ALR
- altitude
- Anaphylaxis
- Angioedema
- angiotensin-convertingenzyme2
- angiotensin-convertingenzymeII
- antibiotics
- Antibodies
- antibody
- antibody-dependentenhancement
- antibodydynamics
- Antiepileptic drugs hypersensitivity
- APOE
- ARPC1B
- Asthma
- asthma control
- asthma exacerbations
- asymptomatic
- atopic dermatitis
- Atopic dermatitis
- B cells
- bacterial lysates
- basic mechanisms
- Basophil
- basophil activation test (BAT)
- Bcells
- Beijing
- beta-lactam
- beta-lactam allergy
- bigdata
- biologicals
- Biologics
- biologika
- biomarker
- Biomarkers
- biosafety
- Birch pollen
- blood
- BNT162b2
- bronchial allergen challenge
- bronchial asthma
- BTK
- cabbage
- cancer
- cannabis allergy
- challenge tests
- chemotherapy
- child
- childhood allergies
- childhoodvaccination
- children
- china
- chlorination by-products
- chronic spontaneous urticaria
- chronic urticaria
- chronicrhinosinusitis
- chronicrhinosinusitiswithnasalpolyps
- chronicurticaria
- chronis rhinosinusitis
- climate
- clinical endotypes
- clinical relevance
- clinicalimmunology
- cofactors
- common cold
- community
- companion animals and pets
- Consensus
- consensus document
- contact dermatitis
- containment
- coronavirus
- coronavirusdisease2019
- cost-effectiveness
- cough
- COVID
- COVID-19
- COVID-19 lockdown
- COVID-19 vaccine
- COVID-19[SupplementaryConcept]
- COVID-19diagnostictesting[SupplementaryConcept]
- COVID-19vaccines
- COVID‐19
- COVID19
- CRISPR
- criticalillness
- cross-reactive molecules
- CRSwNP
- Cutaneous manifestation
- cyclosporine
- cytokine
- DAMP
- danger signals
- Danger signs
- Dermatology
- desensitization
- dexamethasone
- DGAKI
- diagnosis
- diet
- Differential diagnosis
- disease burden
- disease transmission
- disinfection by-products
- DNase
- drug allergy
- drug allergy diagnosis
- drug hypersensitivity
- drug provocation test
- drug provocation test (dpt)
- dupilumab
- ECDA
- Education
- efficacy
- Endotype
- Endotypes
- ENT
- environment
- environmentalhealth
- Enzyme-LinkedImmunosorbentAssay[Mesh]
- Epidemiology
- epithelialcell
- ERS/EAACI
- EU
- exacerbations
- experimental models
- exposome
- fermentedvegetable
- Flow cytometry
- flow-diagram
- flowcytometry
- food
- food allergy
- global atlas
- glycans
- grade
- guideline
- guidelines
- health economics
- health-care
- hereditary angioedema
- house dust mites
- housedust mites
- hygiene
- hyperinflammation
- hypersensitivity
- hypersensitivity reactions
- IgE
- immediate reactions
- immune response
- immunecomplex
- immuneresponse
- immunodeficiencies
- immunoglobulinM
- immunoglobulins
- Immunologic tests
- immunotherapy
- Immunotherapy clinical
- Immunotherapy vaccines and mechanisms
- implementationscience
- In vitro assays
- Infections
- inferiorturbinate
- Inflammation
- inflammatoryendotype
- innate immunity
- innateimmunity
- Innovation
- integrated care
- interferon
- international consensus
- intradermal test
- Iodinated contrast media
- italy
- Kawasakisyndrome
- kimchi
- Lactobacillus
- learning methods
- ligelizumab
- lipid transfer protein
- Lolium Perenne
- long-term immunity
- Long-term prophylaxis
- LTP
- LTRA
- lung function
- lung function test
- lymphocyte transformation test (LTT)
- Lymphocytes
- management
- marketing authorization
- Mast cells
- mastocytosis
- mechanisms
- memory B cells
- metabolites
- Metabolomics
- Metalloproteinase 9
- Microbiome
- microbiota
- microRNA
- molecular allergology
- molecularinteractionassay
- monoclonal Abs
- MOOC
- MRGPRX2
- mRNA
- mRNA vaccines
- multi-disciplinary management
- multisysteminflammatorysyndrome
- mumps‐measles‐rubella
- myeloperoxidase
- neonates
- Neutralizing[Mesh]
- neutralizingantibody
- neutrophil extracellular traps (NETs)
- neutrophilextra-cellulartraps(NETs)
- neutrophils
- newborns
- NLR
- non-immediate reactions
- non-specialist care
- non-steroidal anti-inflammatory drugs (NSAID)
- noninvasive diagnosis
- Novel mechanisms
- NSAID
- nsaid-exacerbated respiratoy disease (NERD)
- nutrients
- occupational allergies
- occupational exposure
- Olink
- omalizumab
- omic
- One Health
- Oral allergy syndrome (OAS)
- oral corticosteroids
- outbreak
- Paediatrics
- PAMP
- pandemic
- patient reported outcome
- patient-centered care
- peak expiratory flow
- pediatric
- pediatric aspects
- pediatrics
- Peptide immunotherapy
- perioperative allergy
- pharmacoeconomics
- Phenotype
- phenotypes
- pneumonia
- Polish Allergology Society
- Pollen
- Pollen monitoring
- pollution
- PRACTALL
- precision medicine
- prediction
- preschool
- Prevention
- primary care
- probiotics
- proresolvinglipids
- protection
- protectiveantibodies
- psychological effects
- pulmonary rehabilitation
- Quality-of-life
- qualitycriteria
- race
- randomized controlled trial
- Rapid drug desensitization
- real-world evidence
- recreational exposure
- RED-ZONE
- regulation
- regulatory authorities
- RELEVANT
- respiratory allergy
- Rhinitis
- rhinoconjuctivitis
- risk assessment
- risk factors
- riskfactors
- RLR
- safety
- SANI
- SARS-CoV
- SARS-CoV-2
- SARS-CoV-2 vaccine
- SARS‐CoV‐2
- SCARs (severe cutaneous adverse drug reactions)
- SCIT
- self-care
- self‐management
- sensitization
- severe allergic reactions
- severe asthma
- Severe cutaneous adverse drug reactions (SCARs)
- SevereAcuteRespiratorySyndromeCoronavirus2[SupplementaryConcept]
- severeallergicreactions
- severity
- sinus
- skin allergy
- skin diseases
- skin test
- sleep pattern
- SLIT
- smell
- Sports
- sputuminduction
- Stallergenes Greer
- standardization
- Stevens-Johnson syndrome (SJS)
- subcutaneous immunotherapy
- sublingual immunotherapy
- sulforaphane
- supplementation
- survey
- Symptom scale
- systematic review
- T cells
- t2 diseases
- Tcells
- TLR
- TMPRSS2
- tolerance
- trainedimmunity
- transition
- translationalresearch
- transmissionofdisease
- treatment
- UCARE
- umfrage
- unmet needs
- Urticaria
- urticaria diagnosis
- urticaria treatment
- vaccine
- Vaccines
- venom immunotherapy
- Viral reactivation
- Virus
- WAO
- wheezing
- white paper
- Xlinkedagammaglobulinemia
- young
- young adults
Author
- Adamiec, A.
- Adcock, I.
- Agache, I.
- Aggelides, X.
- Akdis, C.A.
- Akdis, M.
- Akin, C.
- Allegri, P.
- Alvarez-Cuesta, E
- Alvarez-Perea, A.
- Alvaro-Lozano, M.
- Alviani, C.
- Ambrożej, D.
- Angier, E.
- Anna Pastorello, E.
- Annesi-Maesano, I.
- Antje Faber, M.
- Antolin-Amerigo, D.
- Antunes, C.
- Apoil, P.
- Arasi, S.
- Arcolaci, A.
- Arkhipova, S.
- Arnold, A.
- Asero, R.
- Atanaskovic-Markovic, M.
- Ayane, A.
- Bachert, C.
- Baerenfaller, K.
- Ballmer-Weber, B.K.
- Barbaud, A.
- Barber, D.
- Bartel, S
- Bartra, J.
- Baumann, R
- Bavbek, S.
- Bazan-Socha, S.
- Beck, L.
- Bedbrook, A.
- Bégin, P.
- Beken, B.
- Bergmann, C.
- Bernard, A.
- Bernstein, D.
- Bernstein, J.
- Besednjak-Kocijancic, L.
- Beyer, K.
- Bikov, A.
- Bindslev-Jensen, C.
- Birrell, F.
- Bisyuk, y.
- Bjermer, L.
- Blanca-Lopez, N.
- Blumchen, K.
- Boccabella, C.
- Bohle, B.
- Böhm, I.
- Bonini, M.
- Bousquet, J.
- Boyce, J.
- Boyle, R.
- Bozkurt, B.
- Branicka, O.
- Braun, A.
- Braunstahl, G.
- Brignole-Baudouin, F.
- Brockow, K.
- Brough, H.A.
- Brucker, H.
- Burks, W.
- Caballero, M.
- Cabanillas, B.
- Cabrera, M.
- Calder, V.
- Calderon, M
- Campbell, D.
- Canonica, G.W.
- Cardoso, B.
- Caruso, C.
- Castells, M.
- Caubet, J-C.
- Caubet, J.-C.
- Cavaleiro Rufo, J.
- Cecchi, L.
- Chaker, A.
- Chan, E.
- Chawes, B.
- Chivato, T.
- Cianferoni, A.
- Clark, A.
- Clark, E.
- Clini, E.
- Cogo, A.
- Comberiati, P.
- Cornejo-Garcia, JA
- Correia-de-Sousa, J.
- Corren, J.
- Corrigan, C.
- Coutinho, C.
- Couto, M.
- Craig, T.
- Cullinan, P.
- Cunha, I.
- Custovic, A.
- D'Amato, G.
- Davidescu, L.
- de Blay, F.
- de Flokstra Blok, B
- de Jong, N.
- de las Vecillas, L.
- de Silva, D.
- de Swart, R.
- de Waard-van der Spek, F.
- del Giacco, S.
- Delgado, L.
- Demoly, P
- Descamps, V.
- Deshpande, D.
- di Bona, D.
- Diamant, Z.
- Diaz Perales, A.
- Diwakar, L.
- Doğru, M.
- Domínguez Andrés, J.
- Doña, I.
- Dramburg, S.
- Drijver-Messelink, MT
- du Toit, G.
- Duca, B.
- DunnGalvin, A.
- Durham, S.
- Ebo, D.G.
- Eguiluz-Gracia, I.
- Eguiluz, I.
- Eiwegger, T.
- Elenius, V
- Emson, C.
- Erkekol, F.
- Eyerich, K.
- Faber, M.A.
- Farkas, H.
- Fauquert, J.
- Feketea, G.
- Fernández Santamaría, R.
- Fernández-Rivas, M.
- Fieten, KB
- Firinu, D.
- Flokstra – de Blok, BMJ
- Flood, B.
- Florsheim, E.
- Fokkens, W.
- Forastiere, F.
- Fu, W.
- Garriga-Baraut, T.
- Garvey, LH
- Gawlik, R
- Gelincik, A.
- Geng, B.
- Genuneit, J.
- Gerth van Wijk, R.
- Gevaert, P.
- Giménez-Arnau, A.
- Giovannini, M.
- Golding, M.
- Gomes, E.R.
- Gomez, F.
- González Díaz, S
- Goodman, R.
- Gore, C.
- Gowland, M.
- Greenhawt, M.
- Gunawardana, N.
- Gutermuth, J.
- Guttman-Yassky, E.
- Halken, S.
- Hamilton, J.
- Hartmann, K.
- Heffler, E.
- Heldner, A.
- Hellings P.
- Herth, F.
- Hilger, C.
- Hoffmann-Sommergruber, K.
- Hoffmann, H-J.
- Holgate, S.
- Holmdahl, I.
- Holmes, S.
- Horvath, I.
- Hox, V.
- Huang, Y
- Jackson, D.
- Jacobsen, L.
- Janda, J.
- Janson, C.
- Jeebhay, M.
- Jeimy, S.
- Jensen, B.
- Jiménez-Saiz, R.
- Johnston, S.
- Jones, A.
- Jutel, M.
- K Chu, D.
- Kalayci, O.
- Kang, M.
- Kappen, J.
- Kase Tanno, L.
- Kelleher, M.
- Khaitov, M.
- Khaleva, E.
- Kheradmand, F.
- Kidon, M.
- Kılıç, A.
- Kleine-Tebbe, J.
- Kleuskens, M.
- Klimek, L.
- Knibb, R.
- Knol, E.
- Kocatürk, E.
- Kocks, J.
- Köhler, V.
- Konstantinopoulos, A.P.
- Korath, ADJ
- Kortekaas Krohn, I.
- Kosowska, A.
- Kothalawala, D.
- Kozlik, P.
- Kündig, T.
- Kuyucu, S.
- Kuziemski, K.
- Lack, G.
- Lang, D.
- Larché, M.
- Lee, Y.
- Leonardi, A.
- Luengo, O.
- Macchia, L.
- Madrigal-Burgaleta, R.
- Mahler, V.
- Maleki, S.
- Malmberg, PL.
- Marrs, T.
- Martins, C.
- Maspero, J.
- Mathioudakis, A.
- Matricardi, P
- Matucci, A.
- Maurer, M.
- Mayorga, C.
- McSorley, H.
- Meyer, R.
- Mockenhaupt, M.
- Moloudizargari, M.
- Montimer, K.
- Mori, F.
- Mortz, C.G.
- Mösges, R.
- Muraro, A
- Myszkowska, D.
- Nadeau, K.C.
- Nasser, S.
- Nwaru, B.
- O’Mahony, L.
- Ogese, M.
- Ogg, G.
- Ollert, M.
- Ong, P.Y.
- Pagani, M.
- Palomares, O.
- Paoletti, G.
- Papadopoulos, N.
- Paplinska-Goryca, M.
- Park, H.
- Pastorello, E.A.
- Pavord, I.
- Peden, D.
- Pepys, J.
- Pérez de Llano, L.
- Perkin, M.
- Permaul, P.
- Peters, A.
- Pfaar, O.
- Pinnock, H.
- Pite, H.
- Pitsios, C.
- Poli, A.
- Popescu, F.
- Portelli, M.
- Qazi, K.
- Rabin, R.L.
- Radzikowska, U.
- Reese, I.
- Reginald, K.
- Renz, H.
- Reynolds, N.
- Ricci, C.
- Riggioni, C.
- Ring, J.
- Roberts, G
- Roberts, G.
- Rodrigo-Muñoz, J.
- Rossi, A.
- Rostaher, A.
- Rovati, GE
- Rudenko, M.
- Rukhadze, M.
- Rustemeyer, T.
- Ryan, D.
- Sabato, V.
- Sabouraud, D.
- Sadeghi, S.
- Salapatek, A.
- Sanchez-Garcia, S.
- Sandoval-Ruballos, M.
- Santos, A.
- Scadding, G
- Scala, E.
- Scheib, N.
- Scherrer, K.
- Schmid, B.
- Schwarze, J.
- Sediva, A.
- Semernik, O.
- Shamji, M.H.
- Skypala, I.J.
- Smolinska, S.
- Sokolowska, M.
- Song, K.
- Soyer, O.
- Spergel, J.
- Spolak-Bobryk, N.
- Straumann, A.
- Sublett, J.
- Suojalehto, H.
- Suprun, M.
- Swoboda, I.
- Szajewska, H.
- Szymanski, L.
- Tan, B.
- Thibaudon, M.
- Thien, F.
- Thirumala Krishna, M.
- Till, S.J.
- Timmermans, F.
- Tonia, T.
- Torres, M.J.
- Torres, MJ.
- Torun, E.
- Traidl-Hoffmann, C.
- Tramper-Stranders, G.
- Trautmann, A.
- Troy, N.
- Tsabouri, S.
- Tsilochristou, O.
- Untersmayr, E.
- Van Bilsen, J.
- Van Cuilenborg, V.
- van den Berge, M.
- van Neerven, R.
- van Ree, R.
- Van Weissenbruch, R.
- Vandenplas, Y.
- Vassilopoulou, E.
- Vazquez-Ortiz, M.
- Vega Castro, A.
- Venter, C.
- Verhasselt, V.
- Vieths, S.
- Vlieg- Boerstra, B.
- von Mutius, E.
- Vultaggio, A.
- Walter, J.
- Wardzynska, A.
- Warner, A.
- Weidner, J.
- Werfel, T.
- Wiehn, E.
- Wong, C.
- Worm, M.
- Worm, M.
- Zhang, L.
- Zissler, UM
- Zuberbier, T.

Guideline 2022

Molecular Allergology User’s Guide 2.0
- Hoffmann-Sommergruber, K.
- de las Vecillas, L.
- et al
Read about this Guideline
Guideline 2022

Allergen Immunotherapy Guidelines Part 2: Recommendations
- Muraro, A
Read about this Guideline
Guideline 2022

Allergen Immunotherapy Guidelines Part 1: Systematic reviews
- Muraro, A
Read about this Guideline
Guideline 2022

EAACI guideline: Anaphylaxis (2021 update)
- Muraro, A
- Alviani, C.
- et al
Read about this Guideline
Guideline 2022

EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update)
- Halken, S.
- de Silva, D.
- et al
Read about this Guideline
Guideline 2021

EAACI Biologicals Guidelines – Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old
- Agache, I.
- Akdis, C.A.
- et al
Read about this Guideline
Guideline 2020

EAACI Biologicals Guidelines – dupilumab for children and adults with moderate‐to‐severe atopic dermatitis
- Agache, I.
- Akdis, C.A.
- et al
Read about this Guideline
Guideline 2020

EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthma
- Roberts, G
- Knibb, R.
- et al
Read about this Guideline
Guideline 2020

Efficacy and Safety of treatment with dupilumab for severe asthma A systematic review for the EAACI Guidelines – recommendations on the use of biologicals in severe asthma
- Agache, I.
Read about this Guideline
Guideline 2020

EAACI Biologicals Guidelines – Recommendations for severe asthma
- Agache, I.
Read about this Guideline
Guideline 2020

EAACI Guideline on the effective transition of adolescents and young adults with allergy and asthma
- Roberts, G
Read about this Guideline
Guideline 2019

Allergen Immunotherapy Guidelines: House dustmite-driven allergic asthma
- Agache, I.
Read about this Guideline
Guideline 2016

Molecular allergology user’s guide
- Matricardi, P
Read about this Guideline

Show more Guidelines (7)

Guidelines

All Guidelines

What are you looking for?

Molecular Allergology User’s Guide 2.0

Allergen Immunotherapy Guidelines Part 2: Recommendations

Allergen Immunotherapy Guidelines Part 1: Systematic reviews

EAACI guideline: Anaphylaxis (2021 update)

EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update)

EAACI Biologicals Guidelines – Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old

EAACI Biologicals Guidelines – dupilumab for children and adults with moderate‐to‐severe atopic dermatitis

EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthma

Efficacy and Safety of treatment with dupilumab for severe asthma A systematic review for the EAACI Guidelines – recommendations on the use of biologicals in severe asthma

EAACI Biologicals Guidelines – Recommendations for severe asthma

EAACI Guideline on the effective transition of adolescents and young adults with allergy and asthma

Allergen Immunotherapy Guidelines: House dustmite-driven allergic asthma

Molecular allergology user’s guide